Women with endometriosis more likely to be diagnosed with STIs – study

Women with endometriosis or painful periods were four to five times more likely to receive an STI diagnosis, a large Japanese study found.
Endometriosis occurs when tissue similar to the lining of the womb grows outside the womb. Although not strictly a menstrual disorder, it can cause pain, irregular periods and infertility.
The study was led by researchers at the University of Yamanashi and funded by Rohto Pharmaceutical Co.
The analysis examined health insurance claims from more than 3.4m women aged 40 or younger who had at least one healthcare visit during 2023.
Around 260,000 women, or 7.5 per cent of those included, had been diagnosed with endometriosis, dysmenorrhoea or both.
Dysmenorrhoea is the medical term for painful periods or menstrual cramps.
Women with endometriosis, dysmenorrhoea or both were four to five times more likely to have a recorded diagnosis of a sexually transmitted infection, or STI, than women without the conditions.
Diagnoses were significantly more common across every category examined, including chlamydia, gonorrhoea, trichomoniasis, genital herpes and other STIs.
Chlamydia was recorded in 3.5 per cent of women with menstruation-related conditions, compared with 0.7 per cent of those without them.
This represented a fivefold increase and the largest difference in prevalence between the two groups.
Gonorrhoea was diagnosed in 0.9 per cent of women with the conditions, compared with 0.2 per cent of those without them, also representing an increase of about five times.
Trichomoniasis, genital herpes and other STIs were diagnosed four to five times more often in women with endometriosis, dysmenorrhoea or both.
Women with endometriosis had the highest STI diagnosis rates overall.
Almost five per cent had a recorded chlamydia diagnosis, making it the most common STI in this group and more than seven times as prevalent as among women without menstruation-related conditions.
Women with dysmenorrhoea also had higher diagnosis rates for every STI included in the analysis.
The study found little evidence that hormonal treatments, including low-dose oestrogen-progestin therapy, affected STI diagnosis rates.
Differences between women who used hormonal treatment and those who did not were generally less than one percentage point.
Researchers suggested several possible explanations for the association between menstruation-related conditions and STI diagnoses.
One likely explanation is that women with endometriosis and dysmenorrhoea attend healthcare appointments more often.
As many STIs cause only mild symptoms, women seeking care more frequently for these conditions may be more likely to have infections detected.
Biological and behavioural factors may also play a part.
Menstruation-related conditions, particularly endometriosis, are associated with inflammation, pain during sex and sexual dysfunction, which could influence contraceptive practices and susceptibility to infection.
However, the authors said these possible explanations “remain speculative.”
They cautioned that differences in healthcare-seeking behaviour make it difficult to determine whether women with menstruation-related conditions acquire more infections or are simply more likely to receive a diagnosis.
The authors concluded that the findings underline the importance of STI screening and reproductive health education for women with endometriosis or painful periods.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









